Tetrahydrobiopterin Supplementation Improves Endothelial Function But Does Not Alter Aortic Stiffness in Patients With Rheumatoid Arthritis
- PMID: 26896473
- PMCID: PMC4802470
- DOI: 10.1161/JAHA.115.002762
Tetrahydrobiopterin Supplementation Improves Endothelial Function But Does Not Alter Aortic Stiffness in Patients With Rheumatoid Arthritis
Abstract
Background: Rheumatoid arthritis is a systemic inflammatory condition associated with increased cardiovascular risk that may be due to underlying endothelial dysfunction and subsequent aortic stiffening. We hypothesized that supplementation with tetrahydrobiopterin (BH4) would recouple endothelial nitric oxide synthase and thus improve endothelial function and consequently reduce aortic stiffness.
Methods and results: We conducted 2 randomized, double-blinded, placebo-controlled crossover studies examining 2 separate regimens: an acute regimen, with a single dose of BH4 400 mg versus placebo (n=18), and a short-term regimen, composed of a 1-week treatment with BH4 400 mg once daily versus placebo (n=15). Flow-mediated dilatation and aortic pulse wave velocity were studied 4 times, before and after each treatment phase. Acute BH4 supplementation led to an improvement of flow-mediated dilatation, whereas placebo had no effect (mean±SD of effect difference 2.56±4.79%; P=0.03). Similarly, 1-week treatment with BH4 improved endothelial function, but there was no change with placebo (mean±SD of effect difference 3.50±5.05%; P=0.02). There was no change in aortic pulse wave velocity following acute or short-term BH4 supplementation or placebo (mean±SD of effect difference: acute 0.09±0.67 m/s, P=0.6; short-term 0.03±1.46 m/s, P=0.9).
Conclusion: Both acute and short-term supplementation with oral BH4 improved endothelial function but not aortic stiffness. This result suggests that BH4 supplementation may be beneficial for patients with rheumatoid arthritis by improving endothelial dysfunction and potentially reducing risk of cardiovascular disease. There appears to be no causal relationship between endothelial function and aortic stiffness, suggesting that they occur in parallel, although they may share common risk factors such as inflammation.
Keywords: arteriosclerosis; endothelial function; inflammation; rheumatoid arthritis; tetrahydrobiopterin.
© 2016 The Authors. Published on behalf of the American Heart Association, Inc., by Wiley Blackwell.
Figures
![Figure 1](https://www.ncbi.nlm.nih.gov/pmc/articles/instance/4802470/bin/JAH3-5-e002762-g001.gif)
![Figure 2](https://www.ncbi.nlm.nih.gov/pmc/articles/instance/4802470/bin/JAH3-5-e002762-g002.gif)
Similar articles
-
Acute Tetrahydrobiopterin Improves Endothelial Function in Patients With COPD.Chest. 2018 Sep;154(3):597-606. doi: 10.1016/j.chest.2018.04.028. Epub 2018 Apr 26. Chest. 2018. PMID: 29705218 Clinical Trial.
-
Endothelial dysfunction, endothelial nitric oxide bioavailability, tetrahydrobiopterin, and 5-methyltetrahydrofolate in cardiovascular disease. Where are we with therapy?Microvasc Res. 2018 Sep;119:7-12. doi: 10.1016/j.mvr.2018.03.012. Epub 2018 Mar 27. Microvasc Res. 2018. PMID: 29596860 Review.
-
Acute oral tetrahydrobiopterin administration ameliorates endothelial dysfunction in systemic sclerosis.Clin Exp Rheumatol. 2017 Sep-Oct;35 Suppl 106(4):167-172. doi: 10.55563/clinexprheumatol/cqyllj. Epub 2017 Sep 14. Clin Exp Rheumatol. 2017. PMID: 28980911 Free PMC article.
-
The peroxisome proliferator activated receptor-γ pioglitazone improves vascular function and decreases disease activity in patients with rheumatoid arthritis.J Am Heart Assoc. 2013 Nov 19;2(6):e000441. doi: 10.1161/JAHA.113.000441. J Am Heart Assoc. 2013. PMID: 24252844 Free PMC article. Clinical Trial.
-
The effect of tumor necrosis factor-α antagonists on arterial stiffness in rheumatoid arthritis: a literature review.Semin Arthritis Rheum. 2012 Aug;42(1):1-8. doi: 10.1016/j.semarthrit.2012.02.002. Epub 2012 Apr 3. Semin Arthritis Rheum. 2012. PMID: 22475245 Review.
Cited by
-
Oxidative stress and the role of redox signalling in chronic kidney disease.Nat Rev Nephrol. 2024 Feb;20(2):101-119. doi: 10.1038/s41581-023-00775-0. Epub 2023 Oct 19. Nat Rev Nephrol. 2024. PMID: 37857763 Review.
-
Endothelial dysfunction due to eNOS uncoupling: molecular mechanisms as potential therapeutic targets.Cell Mol Biol Lett. 2023 Mar 9;28(1):21. doi: 10.1186/s11658-023-00423-2. Cell Mol Biol Lett. 2023. PMID: 36890458 Free PMC article.
-
Tetrahydrobiopterin Administration Augments Exercise-Induced Hyperemia and Endothelial Function in Patients With Systemic Sclerosis.Front Med (Lausanne). 2022 Jan 10;8:791689. doi: 10.3389/fmed.2021.791689. eCollection 2021. Front Med (Lausanne). 2022. PMID: 35083247 Free PMC article.
-
Evaluation of the Risk of Getting Peripheral Artery Disease in Rheumatoid Arthritis and the Selection of Appropriate Diagnostic Methods.Cureus. 2020 Aug 16;12(8):e9782. doi: 10.7759/cureus.9782. Cureus. 2020. PMID: 32953298 Free PMC article. Review.
-
Role of the eNOS Uncoupling and the Nitric Oxide Metabolic Pathway in the Pathogenesis of Autoimmune Rheumatic Diseases.Oxid Med Cell Longev. 2020 Apr 13;2020:1417981. doi: 10.1155/2020/1417981. eCollection 2020. Oxid Med Cell Longev. 2020. PMID: 32351667 Free PMC article. Review.
References
-
- Wolfe F, Mitchell DM, Sibley JT, Fries JF, Bloch DA, Williams CA, Spitz PW, Haga M, Kleinheksel SM, Cathey MA. The mortality of rheumatoid arthritis. Arthritis Rheum. 1994;37:481–494. - PubMed
-
- Symmons DP, Jones MA, Scott DL, Prior P. Longterm mortality outcome in patients with rheumatoid arthritis: early presenters continue to do well. J Rheumatol. 1998;25:1072–1077. - PubMed
-
- Lind L, Berglund L, Larsson A, Sundstrom J. Endothelial function in resistance and conduit arteries and 5‐year risk of cardiovascular disease. Circulation. 2011;123:1545–1551. - PubMed
-
- Hansel S, Lassig G, Pistrosch F, Passauer J. Endothelial dysfunction in young patients with long‐term rheumatoid arthritis and low disease activity. Atherosclerosis. 2003;170:177–180. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical